Boje K M, Lakhman S S
Department of Pharmaceutics, School of Pharmacy, University of Buffalo, Buffalo, New York.
J Pharmacol Exp Ther. 2000 May;293(2):545-50.
Excessive production of nitric oxide (NO) in the central nervous system is suspected to contribute to neurodegenerative diseases. Previous studies showed that excessive central nervous system NO increased the permeability of the blood-brain barrier (BBB) during experimental meningitis. The present work hypothesizes that the various NO redox forms (NO(), NO(+), NO(-)) differentially mediate disruption of the BBB. Pharmacological agents that release NO redox forms (i.e., NO prodrugs) were selected based on the rate of NO release and the liberated NO redox form. An in situ rodent brain perfusion preparation was used to administer NO prodrugs into the cerebrovascular circulation, followed by brain perfusion with [(14)C]sucrose, a marker of BBB integrity. Cerebrovasculature infusion of certain NO prodrugs caused a significant, 2- to 5-fold BBB permeability increase in all forebrain regions (P <.01). The NO prodrug rank order of BBB disruption was S-nitroso-N-acetylpenicillamine-beta-cyclodextrin (releases NO(*), NO(+), and NO(-)) > Angeli's salt (NO(), NO(-)) > MAHMA NONOate approximately diethylamine NONOate (NO()) > spermine NONOate (NO()) > DETA NONOate approximately Piloty's acid (negligible NO redox release) approximately saline. When normalized to BBB disruption caused by hyperosmotic mannitol (100%), S-nitroso-N-acetylpenicillamine-beta-cyclodextrin (NO(), NO(+), and NO(-)) elicited approximately 45% disruption, Angeli's salt (NO(), NO(-)) elicited approximately 18% disruption, and the NONOates (NO()) ranged from approximately 0 to 8% disruption. Cerebral blood flows and intracranial pressures were within normal limits for each tested NO prodrug, thereby suggesting that BBB disruption was not secondary to altered cerebral perfusion. Collectively, the results of this work identify that NO() alone exerts modest BBB disruption compared with the specie combination of NO() and NO(-), and the greatest disruption is exerted by the combination of NO(), NO(-), and NO(+).
中枢神经系统中一氧化氮(NO)的过量产生被怀疑与神经退行性疾病有关。先前的研究表明,在实验性脑膜炎期间,中枢神经系统中过量的NO会增加血脑屏障(BBB)的通透性。目前的研究假设,不同的NO氧化还原形式(NO*、NO+、NO-)对BBB破坏的介导作用存在差异。根据NO的释放速率和释放的NO氧化还原形式,选择了能释放NO氧化还原形式的药物制剂(即NO前药)。采用原位啮齿动物脑灌注制剂将NO前药注入脑血管循环,随后用[14C]蔗糖对脑进行灌注,[蔗糖是BBB完整性的标志物。向脑血管系统输注某些NO前药会导致所有前脑区域的BBB通透性显著增加2至5倍(P<.01)。导致BBB破坏的NO前药的顺序为:S-亚硝基-N-乙酰青霉胺-β-环糊精(释放NO*、NO+和NO-)>安吉利盐(NO*、NO-)>MAHMA NONOate约二乙胺NONOate(NO*)>精胺NONOate(NO*)>DETA NONOate约皮洛蒂酸(NO氧化还原释放可忽略不计)>生理盐水。当与高渗甘露醇引起的BBB破坏(100%)进行归一化比较时,S-亚硝基-N-乙酰青霉胺-β-环糊精(NO*、NO+和NO-)引起约45%的破坏,安吉利盐(NO*、NO-)引起约18%的破坏,NONOates(NO*)引起的破坏范围约为0至8%。每种测试的NO前药的脑血流量和颅内压均在正常范围内,因此表明BBB破坏并非继发于脑灌注改变。总的来说,这项工作的结果表明,与NO和NO-的组合相比,单独的NO对BBB的破坏作用较小,而NO*、NO-和NO+的组合对BBB的破坏作用最大。